查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1987984

Buprofezin市場：2026-2032年全球市場預測（按劑型、作物、應用方法、最終用戶和銷售管道）

Buprofezin Market by Formulation Type, Crop Type, Application Method, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年，Buprofezin市值為 8.0181 億美元，預計到 2026 年將成長至 8.4945 億美元，複合年成長率為 5.87%，到 2032 年將達到 11.9547 億美元。

主要市場統計數據
基準年 2025 8.0181億美元
預計年份：2026年 8.4945億美元
預測年份 2032 1,195,470,000 美元
複合年成長率 (%) 5.87%

權威介紹Buprofezin：作為昆蟲生長調節劑的作用機制、在主要作物中的應用、監管和管理背景。

在現代綜合蟲害管理（IPM）體系中，Buprofezin作為一種昆蟲生長調節劑，佔據著獨特的地位。它能抑制主要吸汁害蟲的蛻皮和發育。農民依靠其標靶作用機制來控制粉蝨、介殼蟲、葉蟬和其他半翅目害蟲的族群數量，這些害蟲威脅棉花、水稻、蔬菜和某些水果的生長。由於Buprofezin作用於幼蟲階段而非立即擊倒害蟲，因此在抗藥性控制和殘留因素是戰術性時，它可以與化學和生物防治劑有效聯合使用。

技術、監管和分銷方面的變化正在重新定義Buprofezin產品的配方、監管和在作物系統中的部署方式。

隨著多項變革性趨勢的交匯，Buprofezin的應用格局正在發生變化，農作物保護產品的研發、行銷和使用方式也隨之重塑。精密農業和數位化決策工具改變了施用時間和劑量選擇，使種植者能夠根據即時病蟲害監測結果，將Buprofezin納入針對性防治措施。同時，製劑科學也在不斷發展，以確保其與混合夥伴的兼容性，提高附著力、耐雨性和作物安全性，進而影響該產品在不同種植系統中的應用。

2025 年的關稅環境如何對供應鏈、採購和分銷產生連鎖反應，從而重塑Buprofezin製劑和原料的取得模式。

美國2025年實施的關稅和貿易措施對Buprofezin等產品產生了連鎖的間接影響，這些產品依賴全球供應鏈獲取活性成分、惰性成分和製劑服務。某些前驅化學品和包裝材料的進口成本上升，增加了從國際採購原料的製劑生產商的單位成本，迫使採購團隊重新評估其供應商組合，優先考慮在地採購和供應關係多元化。因此，一些生產商調整了生產順序和庫存策略，以降低關稅變化帶來的風險，並確保在關鍵種植季節的供應連續性。

詳細的細分洞察揭示了配方選擇、作物類型、應用方法、最終用戶概況和銷售管道如何共同影響採用Buprofezin的決策。

透過對關鍵細分維度的深入分析，我們揭示了Buprofezin產品的不同需求促進因素、應用偏好和商業化策略。相關人員會根據製劑類型評估乳化劑、顆粒劑、懸浮劑和可濕性粉劑在特定施用時間、作物安全性以及操作人員要求方面的適用性。當需要快速混合和與界面活性劑相容時，乳化劑通常是首選；而顆粒劑則可透過土壤和水在稻田和廣​​域施用中實現高度精準的施用。在需要確保葉面接觸和在複雜作物冠層上均勻覆蓋才能達到最佳效果的情況下，懸浮劑和可濕性粉劑仍然非常實用。

美洲、歐洲、中東和非洲以及亞太地區在農業、法規和分銷方面的細微區域差異決定了產品的使用和商業化路徑。

區域趨勢影響著Buprofezin在不同種植系統中的應用、監管和商業化方式。在美洲，噻嗪酮的應用模式反映了特殊作物和農作物需求的混合。技術支援和經銷商網路在將標籤限制轉化為田間實踐方面發揮核心作用，種植者通常尋求將噻嗪酮與適用於棉花、蔬菜和水果作物系統的更廣泛的病蟲害防治工具相結合。該地區的監管合作和管理計劃優先考慮工人安全和環境風險降低，從而影響製劑的選擇和施用時間。

企業層面的策略挑戰主要集中在配方創新、監管合規、銷售管道合作和服務整合等方面，以保持競爭優勢。

製造商、製劑製造商和服務供應商之間的競爭格局主要圍繞著製劑創新、法規專業知識和銷售管道覆蓋範圍。主要企業優先投資於製劑平台，以增強與精準噴灑技術的兼容性，保持對目標複雜害蟲的有效性，並降低工人接觸風險。同時，契約製造和自有品牌協議為區域性製劑製造商創造了機會，使其能夠根據當地作物系統和法規條件客製化產品，從而提高其市場准入的靈活性。

針對製造商和經銷商的具體建議，以加強供應韌性、促進管理並最佳化Buprofezin產品的商業化。

產業領導企業可以採取多項切實可行的措施來增強產品的穩定性、維持藥效並擴大Buprofezin的合理使用範圍。首先，應優先研發更易於使用、減少工人接觸並增強與綜合蟲害管理 (IPM) 實踐相容性的配方。投資於助劑科學和噴灑系統可以降低推廣門檻，並延長產品在其整個生命週期中的效用。其次，應建立健全的管理和抗藥性管理計劃，包括清晰的標籤說明、針對經銷商和顧問的培訓舉措，以及有助於作物輪作和混配選擇的監測通訊協定。

採用高度透明的混合調查方法，結合一手訪談、監管和技術文獻綜述以及實地檢驗，全面檢驗Buprofezin的實際應用。

本研究採用混合調查方法，結合一手訪談、監管文件審查、技術文獻整合和實地檢驗，以確保獲得穩健且多角度的研究結果。一手定性訪談對象包括作物保護專家、製劑科學家、註冊監管官員、經銷商和種植者顧問，旨在了解田間實踐和策略重點。補充的二手分析則利用同行評審的昆蟲學和農業化學品文獻、公開的監管文件以及公司資訊披露，來闡明藥效概況、殘留控制措施和標籤限制等問題。

總之，綜合分析強調了管理、供應彈性和協調的商業策略的必要性，以及Buprofezin作為永續農業化學品的角色。

總之，Buprofezin仍是綜合蟲害管理方案中防治棉花、稻米、蔬菜和某些水果作物中特定吸汁害蟲的有效工具。儘管監管和貿易環境對供應的持續性和成本結構構成挑戰，但製劑技術的進步和數據驅動的應用實踐進一步增強了噻嗪酮的作用。來自各方的壓力，例如對產品管理的期望、通路的變化以及貿易政策的轉變，都要求我們在採購、產品開發以及與生產商的合作方面採取適應性措施。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章Buprofezin市場按劑型分類

  • 乳化濃縮液
  • 顆粒
  • 用於懸浮液的懸浮液溶液
  • 可濕性粉

第9章Buprofezin市場：依作物類型分類

  • 棉布
  • 水果
    • 莓果
    • 柑橘
    • 核果
  • 米
  • 蔬菜
    • 水果和蔬菜
    • 綠葉蔬菜
    • 根莖類

第10章：按應用方法分類的Buprofezin市場

  • 葉面噴布
  • 種子處理
  • 土壤處理

第11章Buprofezin市場：依最終用戶分類

  • 大型農場
  • 小規模農場

第12章Buprofezin市場：依銷售管道分類

  • 直銷
  • 銷售代理
  • 線上

第13章Buprofezin市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章Buprofezin市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章Buprofezin市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國Buprofezin市場

第17章：中國Buprofezin市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Adama Agricultural Solutions Ltd.
  • Albaugh LLC
  • Anmol Biotech Private Limited
  • Aristo Bio-tech And Lifescience Limited
  • Bayer AG
  • Bharat Group
  • Biostadt India Limited
  • Canary Agro Chemicals Private Limited
  • Croda International PLC
  • Dhanuka Agritech Limited
  • Gharda Chemicals Limited
  • Hebei Enge Biotech Co., Ltd.
  • Insecticides（India）Limited
  • Jaffer Group
  • Jaivik Crop Care LLP
  • Jiangsu Changqing Agrochemical Co., Ltd.
  • Kenvos AG
  • King Quenson Group
  • Merck KGaA
  • Nihon Nohyaku Co., Ltd.
  • Nippon Soda Co., Ltd.
  • Nova Agritech Limited
  • Nufarm Limited
  • Paras Crops Limited
  • Parijat Industries India Pvt. Ltd.
  • Rallis India Limited by Tata Chemicals Limited
  • Shandong United Pesticide Industry Co., Ltd.
  • Sumitomo Chemical Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • UPL Limited
Product Code: MRR-2B4B2861EC8B

The Buprofezin Market was valued at USD 801.81 million in 2025 and is projected to grow to USD 849.45 million in 2026, with a CAGR of 5.87%, reaching USD 1,195.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 801.81 million
Estimated Year [2026] USD 849.45 million
Forecast Year [2032] USD 1,195.47 million
CAGR (%) 5.87%

An authoritative introduction to buprofezin covering its insect growth regulator mode of action, primary crop applications, regulatory and stewardship context

Buprofezin occupies a distinct position within contemporary integrated pest management frameworks as an insect growth regulator that disrupts molting and development in key sap-sucking pests. Agricultural practitioners rely on its targeted mode of action to manage populations of whiteflies, scale insects, planthoppers, and other hemipteran pests that threaten cotton, rice, vegetables, and certain fruit categories. Because it affects immature stages rather than providing acute knockdown, buprofezin integrates effectively with complementary chemistries and biological agents when resistance mitigation and residue considerations shape tactical decisions.

Regulatory scrutiny and stewardship commitments increasingly influence the way formulators and applicators deploy buprofezin. Consequently, formulators have invested in delivery formats that optimize crop safety and operator handling while minimizing non-target exposure. In parallel, growers and advisors have adapted application timing and tank-mix strategies to preserve product efficacy across successive pest generations. Transitioning from single-season interventions toward season-long pest management programs, stakeholders emphasize rotation, monitoring, and compatibility with beneficial insect populations.

Taken together, these dynamics frame the current discourse around buprofezin: it is a strategic tool for controlling specific pest complexes, yet its long-term utility depends on coordinated stewardship, formulation innovation, and alignment with evolving regulatory expectations. Those factors shape procurement decisions, extension messaging, and product development roadmaps in practical ways.

Transformative technological, regulatory, and distributional shifts that are redefining how buprofezin products are formulated, regulated, and deployed across crop systems

The landscape for buprofezin is shifting as several transformative trends converge to reshape how crop protection products are developed, marketed, and used. Precision agriculture and digital decision-support tools have changed application timing and dosage selection, enabling growers to integrate buprofezin into targeted interventions informed by real-time pest monitoring. At the same time, formulation science has evolved to address compatibility with tank-mix partners and to improve adherence, rainfastness, and crop safety, which in turn influences product uptake across diverse cropping systems.

Regulatory tightening and heightened scrutiny on environmental and operator safety have accelerated demand for robust stewardship programs and transparent data packages. Consequently, manufacturers and registrants place greater emphasis on residue characterization, non-target risk assessments, and label clarity. Supply chain dynamics have also changed, as global sourcing and raw material availability prompt formulators to re-evaluate manufacturing footprints and contract partnerships. In addition, shifts in distribution behavior - including expanding direct-to-grower engagement and the growth of online procurement channels - are altering how technical support and training are delivered.

These forces operate together: innovation in formulation and data-driven application practices supports compliance and efficacy, while evolving distribution and supply arrangements change how information and product reach end users. Stakeholders who anticipate and respond to these shifts can protect efficacy, reduce regulatory friction, and capture operational efficiencies that strengthen long-term product viability.

How the 2025 tariff environment produced cascading supply chain, procurement, and distribution effects that reshaped access to buprofezin formulations and inputs

The implementation of tariffs and trade measures by the United States in 2025 created a cascade of indirect effects for products like buprofezin that rely on global supply chains for active ingredients, inert components, and formulation services. Increased import costs for certain precursor chemicals and packaging materials raised the unit cost base for formulators who sourced components internationally, prompting procurement teams to reevaluate supplier portfolios and to prioritize localized or diversified supply relationships. In turn, some manufacturers adjusted production sequencing and inventory policies to mitigate exposure to tariff volatility and to preserve continuity of supply for key cropping periods.

At the distribution and end-user level, cost pass-through dynamics varied by channel and customer type. Large agricultural operations with integrated purchasing and longer-term procurement contracts absorbed short-term input price movements more easily than small-scale farms that depend on spot purchases and may face tighter working capital constraints. Moreover, tariff-driven changes fostered reconfiguration in trade flows, encouraging some suppliers to seek alternative export destinations or to accelerate domestic registration and production plans in tariff-affected markets.

Importantly, the policy environment stimulated closer collaboration between registrants, compliance specialists, and commercial teams to ensure uninterrupted access to labeled products while remaining compliant with regulatory obligations. In sum, tariff developments in 2025 heightened focus on supply chain resilience, supplier diversification, and contractual strategies that buffer growers and formulators from episodic trade disruptions.

Granular segmentation insights revealing how formulation choices, crop categories, application methods, end-user profiles, and sales channels collectively shape buprofezin deployment decisions

Insights across key segmentation dimensions reveal differentiated demand drivers, application preferences, and commercialization strategies for buprofezin products. Based on formulation type, stakeholders evaluate emulsifiable concentrates, granules, suspension concentrates, and wettable powders for their fit with specific application windows, crop safety profiles, and operator handling requirements; emulsifiable concentrates often appeal where rapid mixing and compatibility with surfactants matter, while granule formats can offer targeted soil- or water-delivered options for paddy or broadcast applications. Suspension concentrates and wettable powders remain valuable where foliar contact and uniform coverage across complex canopies determine efficacy.

Based on crop type, users tailor selection to the pest complex and crop physiology. Cotton, fruit, paddy, and vegetables each present unique considerations: cotton programs prioritize control of sap-sucking pests across multiple growth stages; fruit applications require attention to preharvest intervals and pollinator exposure, with fruit categories further dissected across berry, citrus, and stone fruit for varying residue and canopy management needs; paddy systems often favor formulations and application windows synchronized with planthopper life cycles; vegetables require agile application timing across fruit vegetables, leafy vegetables, and root vegetables where harvest schedules and residue tolerances differ.

Based on application method, deployment choices cluster around foliar spray, seed treatment, and soil treatment options, with foliar spray remaining the prevalent mode for rapid suppression of active infestations and seed or soil treatments offering prophylactic protection in select systems. Based on end user, the distinction between large scale farms and small scale farms affects purchasing patterns, technical support needs, and willingness to adopt premium formulations or subscription-based supply models. Based on sales channel, direct sales, distributors, and online platforms each present trade-offs between hands-on technical service, reach into fragmented geographies, and convenience; distributors often provide localized agronomic support while direct sales can bundle technical training and stewardship commitments, and online channels increasingly serve smaller buyers seeking transactional convenience. Together, these segmentation lenses inform product development priorities, extension strategies, and channel investments in ways that reflect agronomic realities and commercial constraints.

Regional agronomic, regulatory, and distribution nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine product use and commercialization pathways

Regional dynamics shape how buprofezin is used, regulated, and commercialized across diverse cropping systems. In the Americas, adoption patterns reflect a mix of specialty crop and row crop needs; technical support and distributor networks play a central role in translating label constraints into field practice, and growers often seek integration with broader pest management tools suitable for cotton, vegetables, and fruit systems. Regulatory engagement and stewardship programs in this region emphasize worker safety and environmental risk mitigation, which influence formulation preferences and application timing.

In Europe, Middle East & Africa, regulatory frameworks and regional climatic diversity create heterogeneous demand and approval conditions. Some jurisdictions emphasize stringent residue and non-target species assessments that shape label language and permissible use patterns, while others prioritize access for key staple or export-oriented crops. Technical advisories and extension networks in these geographies frequently guide growers toward integrated approaches that balance efficacy with compliance and market access objectives.

In Asia-Pacific, agricultural systems characterized by intensive rice cultivation, extensive vegetable production, and significant smallholder presence rely heavily on targeted tools for planthopper and sap-sucking pest complexes. Here, formulations that suit paddy application regimes and mixed-cropping calendars gain traction, and stewardship messaging that accounts for multiple cropping cycles proves essential. Across regions, supply chain configuration, regulatory drivers, and agronomic practices interact to determine which channels, formulations, and advisory models best support effective and sustainable use.

Strategic company-level imperatives focusing on formulation innovation, regulatory stewardship, channel partnerships, and service integration to sustain competitive advantage

Competitive dynamics among manufacturers, formulators, and service providers center on formulation innovation, regulatory expertise, and channel reach. Leading enterprises prioritize investments in formulation platforms that enhance compatibility with precision application technologies and that reduce operator exposure while maintaining efficacy against target pest complexes. At the same time, contract manufacturing and private-label arrangements allow regional formulators to tailor products to local cropping systems and regulatory conditions, creating opportunities for agile market entrants.

R&D teams and regulatory affairs specialists collaborate to build robust data packages that support label renewal, risk mitigation, and stewardship initiatives. Partnerships between technical teams and commercial units increasingly aim to translate efficacy data into actionable extension materials and training programs for distributors and end users. Additionally, companies that offer integrated services - combining product supply with digital advisory tools, monitoring services, or custom formulations - differentiate on the basis of convenience and technical value.

Mergers, licensing arrangements, and distribution partnerships remain important mechanisms for scaling geographic reach and accelerating product registration timelines without duplicative capital investment. In this environment, firms that maintain strong relationships with growers, extension agents, and channel partners can more effectively deploy stewardship programs and respond to evolving regulatory expectations, thereby preserving product relevance over multiple cropping cycles.

Actionable recommendations for manufacturers and distributors to fortify supply resilience, advance stewardship, and optimize commercialization of buprofezin products

Industry leaders can take several practical steps to strengthen product resilience, protect efficacy, and expand responsible use of buprofezin. First, prioritize formulation development that improves ease of use, reduces operator exposure, and enhances compatibility with integrated pest management practices; investing in adjuvant science and delivery systems reduces barriers to adoption and can lengthen product lifecycle utility. Second, build robust stewardship and resistance management programs that combine clear label instructions, train-the-trainer initiatives for distributors and advisors, and monitoring protocols that inform rotation and tank-mix choices.

Third, diversify supply chains by securing multiple qualified suppliers for key inputs and by assessing local or regional manufacturing options to reduce exposure to trade volatility. Fourth, strengthen relationships with end users through bundled services that include agronomic advisory, digital decision-support tools, and field-level diagnostics; these offerings create recurring engagement and improve proper product use. Fifth, engage proactively with regulatory authorities and industry associations to streamline data submissions, address non-target risk considerations, and align residue management strategies with export market requirements.

Finally, tailor commercialization strategies to channel dynamics: support distributors with localized technical materials, develop direct-sales pilots for high-value customers, and design online offerings for smaller buyers who value convenience. By combining technical innovation with supply resilience and targeted commercial models, industry leaders can sustain product relevance while meeting evolving regulatory and grower expectations.

A transparent hybrid research methodology combining primary interviews, regulatory and technical literature review, and field validation to triangulate practical insights on buprofezin use

This research synthesizes insights from a hybrid methodology combining primary interviews, regulatory documentation review, technical literature synthesis, and field-level observation to ensure robust, triangulated findings. Primary qualitative interviews included crop protection specialists, formulation scientists, registrants' regulatory leads, distributors, and grower advisors to capture on-the-ground practices and strategic priorities. Complementary secondary analysis drew on peer-reviewed entomology and agronomy literature, publicly available regulatory filings, and company disclosures to contextualize efficacy profiles, residue management practices, and label constraints.

Field-level observation and practitioner feedback informed assessments of application timing, formulation performance under diverse climatic conditions, and stewardship practices at farm scale. Data triangulation helped reconcile differences between controlled-trial efficacy and practical in-field outcomes, while expert validation workshops reviewed preliminary conclusions to ensure relevance and clarity. Quality assurance measures included cross-referencing regulatory documents against reported use patterns and seeking clarifications from technical interviewees when discrepancies emerged.

Throughout the research process, ethical considerations and confidentiality requirements guided interactions with commercial participants. The methodology emphasizes transparency in source attribution and replicability of approach while acknowledging practical limitations inherent in rapidly evolving regulatory and trade contexts.

Concluding synthesis emphasizing the sustained agronomic role of buprofezin alongside the necessity for stewardship, supply resilience, and coordinated commercial strategies

In conclusion, buprofezin remains a targeted and valuable tool within integrated pest management programs for specific sap-sucking pest complexes across cotton, rice, vegetables, and select fruit crops. Its role is reinforced by formulation advancements and data-driven application practices, even as regulatory scrutiny and trade dynamics challenge supply continuity and cost structures. The combined pressures of stewardship expectations, changing distribution channels, and trade policy shifts necessitate adaptive approaches in procurement, product development, and grower engagement.

Stakeholders that align formulation innovation with robust stewardship, diversify supply relationships, and invest in channel-specific technical support will better sustain efficacy and retain grower confidence. Moreover, integrating digital advisory services and localized training into commercialization strategies strengthens correct use and reduces the risk of resistance development. As the sector evolves, decision-makers should prioritize operational resilience and proactive regulatory engagement to preserve both access and product integrity.

Taken together, these conclusions underscore the importance of coordinated action across R&D, regulatory, supply chain, and commercial functions to maintain the utility of buprofezin in modern crop protection portfolios while addressing environmental and market expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Buprofezin Market, by Formulation Type

  • 8.1. Emulsifiable Concentrate
  • 8.2. Granule
  • 8.3. Suspension Concentrate
  • 8.4. Wettable Powder

9. Buprofezin Market, by Crop Type

  • 9.1. Cotton
  • 9.2. Fruit
    • 9.2.1. Berry
    • 9.2.2. Citrus
    • 9.2.3. Stone Fruit
  • 9.3. Paddy
  • 9.4. Vegetables
    • 9.4.1. Fruit Vegetables
    • 9.4.2. Leafy Vegetables
    • 9.4.3. Root Vegetables

10. Buprofezin Market, by Application Method

  • 10.1. Foliar Spray
  • 10.2. Seed Treatment
  • 10.3. Soil Treatment

11. Buprofezin Market, by End User

  • 11.1. Large Scale Farms
  • 11.2. Small Scale Farms

12. Buprofezin Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online

13. Buprofezin Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Buprofezin Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Buprofezin Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Buprofezin Market

17. China Buprofezin Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Adama Agricultural Solutions Ltd.
  • 18.6. Albaugh LLC
  • 18.7. Anmol Biotech Private Limited
  • 18.8. Aristo Bio-tech And Lifescience Limited
  • 18.9. Bayer AG
  • 18.10. Bharat Group
  • 18.11. Biostadt India Limited
  • 18.12. Canary Agro Chemicals Private Limited
  • 18.13. Croda International PLC
  • 18.14. Dhanuka Agritech Limited
  • 18.15. Gharda Chemicals Limited
  • 18.16. Hebei Enge Biotech Co., Ltd.
  • 18.17. Insecticides (India) Limited
  • 18.18. Jaffer Group
  • 18.19. Jaivik Crop Care LLP
  • 18.20. Jiangsu Changqing Agrochemical Co., Ltd.
  • 18.21. Kenvos AG
  • 18.22. King Quenson Group
  • 18.23. Merck KGaA
  • 18.24. Nihon Nohyaku Co., Ltd.
  • 18.25. Nippon Soda Co., Ltd.
  • 18.26. Nova Agritech Limited
  • 18.27. Nufarm Limited
  • 18.28. Paras Crops Limited
  • 18.29. Parijat Industries India Pvt. Ltd.
  • 18.30. Rallis India Limited by Tata Chemicals Limited
  • 18.31. Shandong United Pesticide Industry Co., Ltd.
  • 18.32. Sumitomo Chemical Co., Ltd.
  • 18.33. Thermo Fisher Scientific Inc.
  • 18.34. UPL Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BUPROFEZIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BUPROFEZIN MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BUPROFEZIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 153. GCC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 154. GCC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 155. GCC BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. G7 BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. G7 BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 177. G7 BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 178. G7 BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 179. G7 BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. NATO BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. NATO BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 185. NATO BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 186. NATO BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 187. NATO BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)